Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Elgene Lim, François Vaillant, Di Wu, Natasha C. Forrest, Bhupinder Pal, Adam H. Hart, Marie Liesse Asselin-Labat, David E. Gyorki, Teresa Ward, Audrey Partanen, Frank Feleppa, Lily I. Huschtscha, Heather J. Thorne, Stephen B. Fox, Max Yan, Juliet D. French, Melissa A. Brown, Gordon K. Smyth, Jane E. Visvader, Geoffrey J. Lindeman

Research output: Contribution to journalArticle

879 Scopus citations

Abstract

Basal-like breast cancers arising in women carrying mutations in the BRCA1 gene, encoding the tumor suppressor protein BRCA1, are thought to develop from the mammary stem cell. To explore early cellular changes that occur in BRCA1 mutation carriers, we have prospectively isolated distinct epithelial subpopulations from normal mammary tissue and preneoplastic specimens from individuals heterozygous for a BRCA1 mutation. We describe three epithelial subsets including basal stem/progenitor, luminal progenitor and mature luminal cells. Unexpectedly, we found that breast tissue from BRCA1 mutation carriers harbors an expanded luminal progenitor population that shows factor-independent growth in vitro. Moreover, gene expression profiling revealed that breast tissue heterozygous for a BRCA1 mutation and basal breast tumors were more similar to normal luminal progenitor cells than any other subset, including the stem cell-enriched population. The c-KIT tyrosine kinase receptor (encoded by KIT) emerged as a key marker of luminal progenitor cells and was more highly expressed in BRCA1-associated preneoplastic tissue and tumors. Our findings suggest that an aberrant luminal progenitor population is a target for transformation in BRCA1-associated basal tumors .

Original languageEnglish (US)
Pages (from-to)907-913
Number of pages7
JournalNature medicine
Volume15
Issue number8
DOIs
StatePublished - Aug 1 2009

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers'. Together they form a unique fingerprint.

  • Cite this

    Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M. L., Gyorki, D. E., Ward, T., Partanen, A., Feleppa, F., Huschtscha, L. I., Thorne, H. J., Fox, S. B., Yan, M., French, J. D., Brown, M. A., Smyth, G. K., Visvader, J. E., & Lindeman, G. J. (2009). Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nature medicine, 15(8), 907-913. https://doi.org/10.1038/nm.2000